Although a direct link between complement 2 (C2) and MASLD has not yet been firmly established, the involvement of the complement system in inflammation and immune responses suggests that C2 may play a role in disease’s progression70–72. The gene discussed is C2; the disease is metabolic dysfunction-associated steatotic liver disease.